Nomura Holdings’s Syneron Medical Ltd ELOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-19,225
Closed -$141K 1814
2016
Q1
$141K Buy
+19,225
New +$138K ﹤0.01% 1332
2015
Q2
Sell
-24,034
Closed -$294K 2195
2015
Q1
$294K Buy
24,034
+11,982
+99% +$133K ﹤0.01% 1344
2014
Q4
$114K Sell
12,052
-47,809
-80% -$461K ﹤0.01% 2135
2014
Q3
$604K Buy
59,861
+22,047
+58% +$224K ﹤0.01% 1700
2014
Q2
$393K Sell
37,814
-1,494
-4% -$16.1K ﹤0.01% 1944
2014
Q1
$482K Buy
+39,308
New +$466K ﹤0.01% 1804
2013
Q4
Sell
-17,925
Closed -$155K 2509
2013
Q3
$155K Sell
17,925
-5,227
-23% -$45.1K ﹤0.01% 1983
2013
Q2
$202K Buy
+23,152
New +$207K ﹤0.01% 1844

Other funds holding ELOS

Nomura Holdings's ELOS Position: Q2 2016 in Review

Nomura Holdings sold out of Syneron Medical Ltd (ELOS) in Q2 2016, closing a stake of 19,225 shares — an estimated $141K sold.

Nomura Holdings first reported a position in ELOS in Q2 2013 and held it in 8 quarters. The position peaked at $604K in Q3 2014. 65 funds tracked by Wall St. Rank hold ELOS as of Q2 2016.

  • Nomura Holdings reported no remaining Syneron Medical Ltd position as of Q2 2016 after selling out during the quarter.
  • Nomura Holdings sold 19,225 Syneron Medical Ltd shares in Q2 2016, an estimated $141K.
  • Nomura Holdings first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 8 quarters.
  • Nomura Holdings's Syneron Medical Ltd position peaked at $604K in Q3 2014.
  • 65 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q2 2016.

Based on Nomura Holdings's 13F filing for Q2 2016, filed 15 Aug 2016.